Guangdong Zhongsheng Pharmaceutical Co., Ltd. - Laporan Laba Rugi (TTM)

Guangdong Zhongsheng Pharmaceutical Co., Ltd.
CN ˙ SZSE ˙ CNE100000HW4
CN¥ 20.59 ↑0.61 (3.05%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Guangdong Zhongsheng Pharmaceutical Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2022
01-01
2022
03-31
2022
06-30
2022
09-30
2023
01-01
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
Revenue 1,923 1,896 2,122 2,321 2,409 2,429 2,489 2,545 2,597 2,676 2,747 2,833 2,756 2,611 2,505 2,493 2,447 2,467 2,461
Change (%) -1.40 11.93 9.36 3.81 0.83 2.47 2.24 2.04 3.06 2.65 3.11 -2.70 -5.29 -4.05 -0.49 -1.82 0.82 -0.28
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 680 659 711 753 801 814 826 876 886 942 1,006 1,060 1,088 1,081 1,073 1,101 1,099 1,135 1,132
Change (%) -3.05 7.96 5.84 6.42 1.58 1.53 5.97 1.18 6.29 6.82 5.39 2.59 -0.58 -0.80 2.66 -0.21 3.34 -0.32
% of Revenue 35.34 34.75 33.52 32.44 33.25 33.50 33.19 34.40 34.11 35.18 36.61 37.42 39.46 41.42 42.82 44.17 44.89 46.02 46.00
Gross Operating Profit 1,243 1,237 1,411 1,568 1,608 1,615 1,663 1,669 1,711 1,735 1,741 1,773 1,669 1,529 1,432 1,392 1,349 1,332 1,329
Change (%) -0.50 14.05 11.13 2.56 0.46 2.94 0.39 2.49 1.39 0.39 1.79 -5.86 -8.35 -6.34 -2.85 -3.09 -1.23 -0.25
% of Revenue 64.66 65.25 66.48 67.56 66.75 66.50 66.81 65.60 65.89 64.82 63.39 62.58 60.54 58.58 57.18 55.83 55.11 53.98 54.00
SG&A 833 852 967 1,084 1,083 1,086 1,103 1,110 1,173 1,173 1,192 1,205 1,127 1,044 1,010 973 993 1,005 1,010
Change (%) 2.24 13.49 12.09 -0.12 0.34 1.56 0.61 5.64 0.07 1.55 1.12 -6.47 -7.34 -3.28 -3.64 2.00 1.27 0.44
% of Revenue 43.35 44.95 45.57 46.71 44.94 44.72 44.33 43.62 45.16 43.85 43.38 42.54 40.89 40.00 40.32 39.05 40.57 40.75 41.04
R&D 135 114 116 120 143 137 139 153 138 157 157 152 149 127 131 131 132 111 97
Change (%) -15.83 2.17 2.99 19.25 -4.10 1.93 9.94 -9.85 13.37 0.04 -3.19 -1.65 -14.60 2.77 0.37 0.73 -15.97 -12.63
% of Revenue 7.02 5.99 5.47 5.15 5.92 5.63 5.60 6.02 5.32 5.85 5.70 5.35 5.41 4.88 5.23 5.27 5.41 4.51 3.95
OpEx 1,658 1,642 1,816 1,982 2,055 2,061 2,092 2,162 2,217 2,296 2,378 2,441 2,387 2,264 2,223 2,216 2,233 2,260 2,244
Change (%) -0.97 10.62 9.12 3.70 0.27 1.51 3.36 2.53 3.54 3.60 2.63 -2.20 -5.14 -1.83 -0.31 0.77 1.23 -0.72
% of Revenue 86.23 86.61 85.59 85.41 85.32 84.84 84.05 84.97 85.38 85.78 86.58 86.17 86.60 86.74 88.74 88.90 91.25 91.61 91.21
Operating Income 265 254 306 339 354 368 397 382 380 380 369 392 369 346 282 277 214 207 216
Change (%) -4.13 20.46 10.75 4.47 4.10 7.82 -3.64 -0.76 0.23 -3.08 6.24 -5.76 -6.23 -18.52 -1.90 -22.58 -3.41 4.54
% of Revenue 13.77 13.39 14.41 14.59 14.68 15.16 15.95 15.03 14.62 14.22 13.42 13.83 13.40 13.26 11.26 11.10 8.75 8.39 8.79
Interest Expense -39 -37 -33 -31 -30 -74 -87 -100 -113 -73 -63 -56 -47 -47 -46 -40 -35 -25 -20
Change (%) -5.51 -10.38 -7.71 -3.66 149.00 18.06 14.26 13.81 -35.27 -14.21 -10.29 -17.29 0.46 -2.86 -12.98 -12.09 -27.30 -21.61
% of Revenue -2.05 -1.96 -1.57 -1.33 -1.23 -3.04 -3.50 -3.91 -4.36 -2.74 -2.29 -1.99 -1.69 -1.80 -1.82 -1.59 -1.42 -1.03 -0.81
Net Income 251 -427 -423 -330 -414 278 295 192 213 322 387 328 353 263 175 142 133 -299 -268
Change (%) -270.22 -0.95 -21.80 25.37 -167.01 6.42 -34.99 10.69 51.48 20.12 -15.12 7.45 -25.38 -33.46 -18.87 -6.72 -325.64 -10.47
% of Revenue 13.03 -22.50 -19.91 -14.24 -17.20 11.43 11.87 7.55 8.19 12.03 14.08 11.59 12.80 10.08 6.99 5.70 5.42 -12.12 -10.89

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista